Crossover: samples of p1 and p2 in different batches? [Bioanalytics]

posted by Ravuri sindhura – India, 2019-09-18 19:16 (970 d 23:00 ago) – Posting: # 20614
Views: 5,758

As per FDA Bioanalytical method validation Guidance for Industry "All study samples from subject should be analysed in a single run, especially for studies designed with repeated measures from individual subjects(eg; crossover or sequential design required for BE studies)".
Can the study samples of same subject in more than single run for cross over design can be analysed i'e analysis of P1 samples and P2 samples can be carried out separately in two different runs? If yes, how it need to be justify to regulatory?


Edit: Category and subject line changed; see also this post #1, #2. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
22,073 posts in 4,629 threads, 1,565 registered users;
online 13 (0 registered, 13 guests [including 5 identified bots]).
Forum time: Monday 18:17 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5